vs
Side-by-side financial comparison of STONERIDGE INC (SRI) and USANA HEALTH SCIENCES INC (USNA). Click either name above to swap in a different company.
USANA HEALTH SCIENCES INC is the larger business by last-quarter revenue ($250.2M vs $205.2M, roughly 1.2× STONERIDGE INC). On growth, USANA HEALTH SCIENCES INC posted the faster year-over-year revenue change (-3.0% vs -6.0%). Over the past eight quarters, USANA HEALTH SCIENCES INC's revenue compounded faster (11.8% CAGR vs -7.4%).
Stoneridge Inc is a global designer and manufacturer of advanced electrical and electronic components, integrated systems, and sensor solutions. It serves automotive, commercial vehicle, off-highway, and aerospace sectors, delivering products that boost vehicle safety, efficiency, connectivity, and environmental performance across key global markets.
Usana Health Sciences, Inc., or USANA, is an American multi-level marketing company based in Salt Lake City, Utah. As of 2021, Usana was the 14th largest direct-selling company in the world by revenue. The company manufactures most of its nutritional products, dietary supplements, and skincare products at a Salt Lake City facility. Its products are sold in 24 countries via a network of independent distributors.
SRI vs USNA — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2027
| Metric | | |
|---|---|---|
| Revenue | $205.2M | $250.2M |
| Net Profit | — | $7.5M |
| Gross Margin | 16.2% | 76.2% |
| Operating Margin | -14.4% | 5.5% |
| Net Margin | — | 3.0% |
| Revenue YoY | -6.0% | -3.0% |
| Net Profit YoY | — | -20.0% |
| EPS (diluted) | $-2.76 | $0.41 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $250.2M | ||
| Q4 25 | $205.2M | $226.2M | ||
| Q3 25 | $210.3M | $213.7M | ||
| Q2 25 | $228.0M | $235.8M | ||
| Q1 25 | $217.9M | $249.5M | ||
| Q4 24 | $218.2M | $213.6M | ||
| Q3 24 | $213.8M | $200.2M | ||
| Q2 24 | $237.1M | — |
| Q1 26 | — | $7.5M | ||
| Q4 25 | — | $180.0K | ||
| Q3 25 | $-9.4M | $-6.5M | ||
| Q2 25 | $-9.4M | $9.7M | ||
| Q1 25 | $-7.2M | $9.4M | ||
| Q4 24 | — | $4.5M | ||
| Q3 24 | $-7.1M | $10.6M | ||
| Q2 24 | $2.8M | — |
| Q1 26 | — | 76.2% | ||
| Q4 25 | 16.2% | 78.2% | ||
| Q3 25 | 20.3% | 77.2% | ||
| Q2 25 | 21.5% | 78.7% | ||
| Q1 25 | 21.2% | 79.0% | ||
| Q4 24 | 19.5% | 82.0% | ||
| Q3 24 | 20.8% | 80.4% | ||
| Q2 24 | 22.7% | — |
| Q1 26 | — | 5.5% | ||
| Q4 25 | -14.4% | 1.7% | ||
| Q3 25 | -1.6% | 0.6% | ||
| Q2 25 | -1.1% | 7.1% | ||
| Q1 25 | -1.5% | 6.3% | ||
| Q4 24 | -2.0% | 3.8% | ||
| Q3 24 | 0.1% | 7.8% | ||
| Q2 24 | 1.4% | — |
| Q1 26 | — | 3.0% | ||
| Q4 25 | — | 0.1% | ||
| Q3 25 | -4.5% | -3.1% | ||
| Q2 25 | -4.1% | 4.1% | ||
| Q1 25 | -3.3% | 3.8% | ||
| Q4 24 | — | 2.1% | ||
| Q3 24 | -3.3% | 5.3% | ||
| Q2 24 | 1.2% | — |
| Q1 26 | — | $0.41 | ||
| Q4 25 | $-2.76 | $-0.10 | ||
| Q3 25 | $-0.34 | $-0.36 | ||
| Q2 25 | $-0.34 | $0.52 | ||
| Q1 25 | $-0.26 | $0.49 | ||
| Q4 24 | $-0.22 | $0.23 | ||
| Q3 24 | $-0.26 | $0.56 | ||
| Q2 24 | $0.10 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $66.3M | $162.8M |
| Total DebtLower is stronger | $180.9M | — |
| Stockholders' EquityBook value | $179.8M | — |
| Total Assets | $551.2M | $739.0M |
| Debt / EquityLower = less leverage | 1.01× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $162.8M | ||
| Q4 25 | $66.3M | $158.4M | ||
| Q3 25 | $54.0M | $145.3M | ||
| Q2 25 | $49.8M | $151.3M | ||
| Q1 25 | $79.1M | $179.6M | ||
| Q4 24 | $71.8M | $181.8M | ||
| Q3 24 | $54.1M | $364.9M | ||
| Q2 24 | $42.1M | — |
| Q1 26 | — | — | ||
| Q4 25 | $180.9M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $201.6M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | $179.8M | — | ||
| Q3 25 | $251.2M | $528.1M | ||
| Q2 25 | $260.5M | $531.1M | ||
| Q1 25 | $253.1M | $529.8M | ||
| Q4 24 | $245.3M | $532.1M | ||
| Q3 24 | $271.4M | $533.1M | ||
| Q2 24 | $270.5M | — |
| Q1 26 | — | $739.0M | ||
| Q4 25 | $551.2M | $742.9M | ||
| Q3 25 | $632.1M | $726.6M | ||
| Q2 25 | $639.4M | $734.5M | ||
| Q1 25 | $657.4M | $746.6M | ||
| Q4 24 | $621.6M | $748.2M | ||
| Q3 24 | $662.5M | $671.3M | ||
| Q2 24 | $666.7M | — |
| Q1 26 | — | — | ||
| Q4 25 | 1.01× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.82× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.8M | — |
| Free Cash FlowOCF − Capex | $2.6M | — |
| FCF MarginFCF / Revenue | 1.3% | — |
| Capex IntensityCapex / Revenue | 3.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $12.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $8.8M | — | ||
| Q3 25 | $3.6M | $-2.0M | ||
| Q2 25 | $10.7M | $12.2M | ||
| Q1 25 | $10.9M | $15.5M | ||
| Q4 24 | $19.2M | $5.8M | ||
| Q3 24 | $10.8M | $29.5M | ||
| Q2 24 | $8.7M | — |
| Q1 26 | — | — | ||
| Q4 25 | $2.6M | — | ||
| Q3 25 | $-2.7M | $-5.2M | ||
| Q2 25 | $7.4M | $7.2M | ||
| Q1 25 | $4.8M | $12.7M | ||
| Q4 24 | $14.0M | $4.0M | ||
| Q3 24 | $4.6M | $27.1M | ||
| Q2 24 | $1.5M | — |
| Q1 26 | — | — | ||
| Q4 25 | 1.3% | — | ||
| Q3 25 | -1.3% | -2.4% | ||
| Q2 25 | 3.3% | 3.0% | ||
| Q1 25 | 2.2% | 5.1% | ||
| Q4 24 | 6.4% | 1.9% | ||
| Q3 24 | 2.2% | 13.6% | ||
| Q2 24 | 0.6% | — |
| Q1 26 | — | — | ||
| Q4 25 | 3.0% | — | ||
| Q3 25 | 3.0% | 1.5% | ||
| Q2 25 | 1.4% | 2.1% | ||
| Q1 25 | 2.8% | 1.1% | ||
| Q4 24 | 2.4% | 0.8% | ||
| Q3 24 | 2.9% | 1.2% | ||
| Q2 24 | 3.0% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 1.27× | ||
| Q1 25 | — | 1.65× | ||
| Q4 24 | — | 1.29× | ||
| Q3 24 | — | 2.78× | ||
| Q2 24 | 3.11× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SRI
| Control Devices | $51.7M | 25% |
| Electronics | $38.0M | 19% |
| EE | $34.2M | 17% |
| SE | $28.6M | 14% |
| NL | $24.5M | 12% |
| Stoneridge Brazil | $14.1M | 7% |
| Asia Pacific | $13.1M | 6% |
USNA
Segment breakdown not available.
